U.S. Markets closed

BioLine Rx Ltd (BLRX)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.8499-0.01 (-1.17%)
At close: 3:59PM EDT

0.8500 0.00 (0.01%)
After hours: 4:00PM EDT

People also watch
CANFCPRXPLXANTHAPRI
  • IGXT (MC $46 M) NDA filing for MEGA thin-flim Cialis (better than Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .GLTA

    2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $46 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .Load up guys before she the MEGA news hit the wire and thank me later .GL

    Intelgenx (IGXT)

    MarketCap $46 Million
    Cash ~$12 Million (including convertible debt) =cash untill 2021+
    Price: 0.70

    NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July
    NDA resubmission for Rizaport (migraine) in early Q3
    Partnership for Tadalafil in 2H 2017

    http://www.biotuesdays.com/features/2017/5/11/intelgenx-has-multi-faceted-bd-approach-for-its-oral-films

    IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.

    Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.

  • Phil the efin moron CEO will have us trading in the pink sheets by years end. K girl was horrible, this f-in moron is a waste of a load.
  • If🌱you🌱want🌱to🌱go🌱far,🌱go🌱together.http://dataunion.tistory.com/10547

    Bioline RX Ltd NASDAQ : BLRX Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.6 In other words, the correlation coefficient of the other stock
    dataunion.tistory.com
  • You suk Phil - Get out!
  • You suk Phil, off yourself
  • got my order filled today!
  • Is it time to make a move on BLRX? check out AWEsome.STOCKS, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • ok, who is phil and what did he/she do?
  • You suckk Phil
  • In the short-term BLRX does not seem to be like a good trade. Yo you should really check out awesom-eSTOCKS, they seem on point with their stocks.
  • Phil is an idiot.......
  • nothing really exciting again long term prospects may be okay but who cares at this point. Glycol Medics has a bitter ml
  • I gotta cancel my order in the morning if it is going down...
  • why is there no reaction to earnings?
  • Major sell orders today and small manipulated buys by a broker / dealer to keep the share price from plummeting below .80, won't be long now before the share prices crashes through the .77 support level.

    Looks like another institutional investor wants out......... Good job phil, you waste of a load!
  • Earning call May 25th. They need to get over $1 before July or they will be delisted. This will hit the $1 mark by July IMO!
  • BLRX Received a delisting notification from the SEC yesterday, May 16th - Nice going Phil you efin waste. Bet most investors now wish that you were a #$%$..............
  • Jason couldn't pick his nose right let alone a stock! Last time they were about to be delisted, the big ugly pump fake drove the share price up on very little volume and then shorts pounded it down to current levelsThis management sucks and needs to be to e elfin product to market and not the shake on #$%$
  • Going to $.77 and possible delisting by years end if they #$%$ up yet another trial Jason is azzwipe
  • There is only one direction for BLRX from here....up and up